Working… Menu
Trial record 1 of 1 for:    BLAZE-4
Previous Study | Return to List | Next Study

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04634409
Recruitment Status : Recruiting
First Posted : November 18, 2020
Last Update Posted : July 21, 2021
AbCellera Biologics Inc.
Shanghai Junshi Bioscience Co., Ltd.
Vir Biotechnology, Inc.
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 25, 2021
Estimated Study Completion Date : November 4, 2021